Terns Pharma Stock (NASDAQ: TERN) stock price, news, charts, stock research, profile.
Open | $4.930 |
Close | - |
Volume / Avg. | 325.368K / 888.003K |
Day Range | 4.930 - 5.230 |
52 Wk Range | 3.260 - 13.510 |
Market Cap | $333.603M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 10.46% |
Days to Cover | 5.52 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Terns Pharma (NASDAQ: TERN) through any online brokerage.
Other companies in Terns Pharma’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH), Zevra Therapeutics (NASDAQ:ZVRA) and SNDL (NASDAQ:SNDL).
The latest price target for Terns Pharma (NASDAQ: TERN) was reported by UBS on Wednesday, March 27, 2024. The analyst firm set a price target for 18.00 expecting TERN to rise to within 12 months (a possible 248.84% upside). 22 analyst firms have reported ratings in the last year.
The stock price for Terns Pharma (NASDAQ: TERN) is $5.16 last updated Today at April 29, 2024 at 2:42 PM EDT.
There are no upcoming dividends for Terns Pharma.
Terns Pharma’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Terns Pharma.
Terns Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.